Current Opinion in Endocrinology, Diabetes and Obesity : Impact Factor & More
eISSN: 1752-2978pISSN: 1752-296X
Share this on:
Key Metrics
CiteScore 
4.8
H-Index
78
Impact Factor
< 5
SJR
Q2Endocrinology
SNIP
1.35
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Opinion in Endocrinology, Diabetes and Obesity
Current Opinion in Endocrinology, Diabetes and Obesity Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1993 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Opinion in Endocrinology, Diabetes and Obesity ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Opinion in Endocrinology, Diabetes and Obesity
Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Adrenal insufficiency diagnosis: new approaches to indeterminate baseline cortisol.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
New horizons for autoimmune hyperthyroidism with FcRn blockers.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Exploring the role of parathyroid hormone in sarcopenia: A review.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
EDITORIAL INTRODUCTION.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Adrenal insufficiency diagnosis: new approaches to indeterminate baseline cortisol.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
New horizons for autoimmune hyperthyroidism with FcRn blockers.
- 6 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Exploring the role of parathyroid hormone in sarcopenia: A review.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
EDITORIAL INTRODUCTION.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation.
- 1 Aug 2026
- Current opinion in endocrinology, diabetes, and obesity
FAQs on Current Opinion in Endocrinology, Diabetes and Obesity
How long has Current Opinion in Endocrinology, Diabetes and Obesity been actively publishing? 
What is the publishing frequency of Current Opinion in Endocrinology, Diabetes and Obesity?
How many articles did Current Opinion in Endocrinology, Diabetes and Obesity publish last year?
What is the eISSN & pISSN for Current Opinion in Endocrinology, Diabetes and Obesity?
What is Citescore for Current Opinion in Endocrinology, Diabetes and Obesity?
What is the H Index for Current Opinion in Endocrinology, Diabetes and Obesity ?
What is SNIP score for Current Opinion in Endocrinology, Diabetes and Obesity?
What is the SJR for Current Opinion in Endocrinology, Diabetes and Obesity?
Who is the publisher of Current Opinion in Endocrinology, Diabetes and Obesity?
